Key result
Alprenolol and atropine administration during neurolept analgesia with local adrenaline infiltration resulted in fewer arrhythmias compared to no beta-blockade.
Why the study?
Does alprenolol combined with atropine prevent adrenaline-induced cardiac arrhythmias in patients receiving local adrenaline infiltration during neurolept analgesia?
Cohort (n=19)
Does alprenolol combined with atropine prevent adrenaline-induced cardiac arrhythmias in patients receiving local adrenaline infiltration during neurolept analgesia?
Prophylactic beta-blockade with alprenolol provides partial protection against adrenaline-induced arrhythmias during neurolept analgesia.
Answers are grounded in this paper and cite their sources.
May support prophylactic alprenolol plus atropine against adrenaline-induced arrhythmias; leaves open confirmation by randomized trials.
The adrenergic beta-receptor blocking drug, alprenolol, was given together with atropine to 15 patients during neurolept analgesia (NLA) in order to prevent adrenaline-induced cardiac arrhythmias. Four patients operated on without adrenergic beta-receptor blockade formed the control group. Three of them developed tachyarrhythmias, ventricular tachycardia, multifocal ventricular extrasystoles and supraventricular tachycardia. All these arrhythmias were terminated by the adrenergic beta-receptor blocking drug, propranolol. The fourth patient developed a temporary sinus tachycardia which did not require any treatment. The adrenergic beta-receptor blockade induced a slight increase in pulse rate with almost no change in arterial blood pressure. The incidence of arrhythmias due to adrenaline infiltration was much less in this group. There was one supraventricular tachycardia and scattered ventricular extrasystoles in two other patients. NLA alone does not protect the heart against adrenaline-induced arrhythmias. It does, however, seem to be compatible with an adrenergic beta-receptor blockade, which in turn provides partial protection against adrenaline-induced arrhythmias. The occasionally developing arrhythmias can then be terminated with specific adrenergic beta blockers.
No takes yet. Share an insight, caveat, or question.
Pekka J. Pöntinen (1978) conducted a cohort in Patients undergoing neurolept analgesia with local adrenaline infiltration (n=19). Alprenolol and atropine vs. No adrenergic beta-receptor blockade was evaluated on Adrenaline-induced cardiac arrhythmias. Alprenolol and atropine administration during neurolept analgesia with local adrenaline infiltration resulted in fewer arrhythmias compared to no beta-blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: